RGNT (NYSEAMERICAN:RGNT) Stock Rating Upgraded by ThinkEquity

RGNT (NYSEAMERICAN:RGNTGet Free Report) was upgraded by investment analysts at ThinkEquity to a “strong-buy” rating in a research note issued to investors on Monday,Zacks.com reports.

RGNT Trading Up 4.0%

RGNT stock opened at $3.35 on Monday. RGNT has a one year low of $3.10 and a one year high of $8.35.

RGNT Company Profile

(Get Free Report)

Regentis Biomaterials Ltd. is a regenerative medicine company dedicated to developing tissue repair solutions which seek to restore the health. Regentis Biomaterials Ltd. is based in Herzliya, Israel.

Further Reading

Receive News & Ratings for RGNT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RGNT and related companies with MarketBeat.com's FREE daily email newsletter.